GSM7910125: mouse_PPARaKO_Rosiglitzone_24_0.1_uM_83; Mus musculus; RNA-Seq
Following treatment with HFPO-DA or positive controls (i.e., GW7647, rosiglitazone, acetaminophen or d-galactosamine) for 12, 24 or 72 h, hepatocytes were lysed using TempO-Seq® Enhanced Lysis Buffer and processed according to the TempO-Seq® protocol by BioSypder Technologies. TempO-Seq® protocol by BioSypder Technologies